Abiopharma

News list

Smith Kevin Raymond Merrill 🟢 acquired 1.5K shares of Inogen Inc (INGN) at $7.99 Transaction Date: Sep 01, 2025 | Filing ID: 000004

Full text

News bot Sept. 3, 2025, 9:02 p.m.
🔍 Smith Kevin Raymond Merrill (Executive)

Company: Inogen Inc (INGN)

Report Date: 2025-09-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,500
Detailed Transactions and Holdings:
- Acquired 1,500 shares of Common Stock at $7.99 per share (Direct)
  Date: 2025-09-01 | Code: A | equity_swap_involved: false | shares_owned_after: 71,774.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares acquired through the Company's 2014 Employee Stock Purchase Plan.